QUBIS

VascVersa is a med-tech company specializing in vascular regeneration.

Sonrai develop applications and interfaces to utilize the data and the resultant outputs of analysis and combine this with AI and ML to make your data predictive.

Aramune Technologies is developing natural, plant derived feed materials which can be mixed with standard animal feeds to replace antimicrobial agents and promote growth.

ŌGI Bio is a newly formed start-up company from The University of Edinburgh with the mission to revolutionize the way that microbes are grown and managed.

The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.

AntennaWare is a developer of antenna technology designed to boost the range and reliability of wireless wearable devices.

VascVersa is a med-tech company specializing in vascular regeneration.

FjordStrong is a marine biodiversity technology company that has developed an underwater survey system. This system, called Auto-release Baited Underwater Video, is designed to survey high conservation value species and protected marine areas.

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company focused on the development and commercialisation of innovative long-acting, biodegradable drug delivery platforms to address ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and ocular infections. Their delivery platforms enable tailored delivery of therapeutics for long-term and can be administered by various routes to the eye. By using their platform technologies, delivery of a broad range of molecules including proteins, peptides, and small molecules can be achieved from 1 week to 1 year. The platform technologies are based on FDA-approved polymers. Their injectable platform, OcuLief™, can be tailored for the treatment of AMD and DR to achieve a long-term release of anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids for 1-12 months. Their preformed platform, EyeLief™, can be tailored for the treatment of Glaucoma and retina diseases, to achieve a long-term release of small or large molecules for 6 months or more. The design strategy of Re-Vana revolves around increasing patient compliance by reducing pain and frequency of treatment, lowering side effects by controlled drug release, and cost saving for health care providers and pharmaceutical companies.

Cibus Analytical operates as a food testing specialist. Cibus Analytical offer a laboratory testing service for food authenticity and safety, as well as extend its product offering to include portable testing tools to allow customers to rapidly test for food authenticity and safety at the point of sampling across global supply chains.

Sonrai develop applications and interfaces to utilize the data and the resultant outputs of analysis and combine this with AI and ML to make your data predictive.

We are Liopa. We were incorporated in 2015 to commercialise more than 15 years of PhD research at QUB in the field of speech and image processing. Using this deep knowledge, we developed an automated lipreading solution. Our technology – rooted in machine learning and AI – can decipher what a person is saying from their lip movements alone. Liopa is the first company to release commercially available VSR (Visual Speech Recognition) technology, with the first application being our SRAVI app (www.sravi.ai). SRAVI is a simple lipreading application that requires just a smartphone. It is bringing a voice to the voiceless. With SRAVI, we help patients who have lost the ability to speak, to communicate with their loved ones & carers. SRAVI is deployed onto a smartphone, and when pointed towards the patient, the app analyses their lip movements to decipher what they are trying to say. SRAVI is being trialled in Intensive Care units within the NHS.

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company focused on the development and commercialisation of innovative long-acting, biodegradable drug delivery platforms to address ophthalmic conditions such as age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and ocular infections. Their delivery platforms enable tailored delivery of therapeutics for long-term and can be administered by various routes to the eye. By using their platform technologies, delivery of a broad range of molecules including proteins, peptides, and small molecules can be achieved from 1 week to 1 year. The platform technologies are based on FDA-approved polymers. Their injectable platform, OcuLief™, can be tailored for the treatment of AMD and DR to achieve a long-term release of anti-vascular endothelial growth factors (anti-VEGF) or corticosteroids for 1-12 months. Their preformed platform, EyeLief™, can be tailored for the treatment of Glaucoma and retina diseases, to achieve a long-term release of small or large molecules for 6 months or more. The design strategy of Re-Vana revolves around increasing patient compliance by reducing pain and frequency of treatment, lowering side effects by controlled drug release, and cost saving for health care providers and pharmaceutical companies.

Cirdan provides informatics and imaging solutions. They offer the design and development of imaging sensors that are produced by using X-ray, near-infrared, and visible light wavelengths in high-performance cameras, enabling healthcare professionals to enhance and speed up the diagnosis of patients.

Titan IC Systems (TICS) is a spin-out from the Institute of Electronics, Communications and Information Technology (ECIT) at Queen's University Belfast, a £40 million world-class centre with a unique focus on blue skies, strategic and industrial research projects.

ProAxsis Ltd. specialises in the development of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection and measurement of active protease biomarkers of disease. Its rapid and easy-to-use tests incorporate patented “ProteaseTags®”; smart molecules which trap an active protease within a complex biological sample and enable a visual readout of its presence. A number of active protease species have been extensively validated as biomarkers of disease activity in areas such as cancer and infection, in addition to respiratory diseases such as bronchiectasis, cystic fibrosis and COPD. Its first immunoassay, for the specific measurement of active neutrophil elastase as a biomarker of lung infection and inflammation, was registered with a European CE Mark in 2016.

ActivWireless allow you to track people or assets, simply. Although the technology is complex, the solution is delivered to customers through easy-to-use software which has been tailored for their industry and needs.

Nuada is a vertically integrated pure-play carbon capture company that is poised to decarbonise heavy industries through its next generation point-source capture technology. The company builds energy-efficient CO2 filtration machines that enable industrial emitters in hard-to-abate sectors to achieve their Net Zero targets whilst minimising the impact on their bottom line.

Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and deliver a bespoke package of the services people need to achieve outstanding results. Using the technology, the sequences of the antibody variable domains which determine its binding specificity are incorporated into human donor sequences creating a panel of full length humanized antibodies for expression. Fully humanized monoclonal antibodies are an essential step in the progression of your drug to the clinic and the in-house expertise at Fusion Antibodies ensures its success. All of Fusion Antibodies services are offered on a fee-for-service basis and is flexible on the elements of the project people would like included. Fusion Antibodies have strong links with the several partners around the globe, allowing it to deliver a complete bespoke package, at an incredible price. Fusion Antibodies was founded on 2001 and is based in Belfast, United Kingdom.

Lagan Technologies Ltd. designs and delivers enterprise case management solutions to government agencies primarily in North America and Europe. Its solutions include Enterprise Case Management software, an integrated case management solution for government organizations; Lagan 311, a performance solution for 311 call centers; Lagan Human Services, an integrated case management solution for human services agencies; and Lagan Department of Motor Vehicles Solution, a tool for managing the processes and records associated with driver licensing, driver history, identity verification, vehicle registration, titling, and inspections. The company's services also include project management, consultancy, installation, testing, integration, education and training, skills transfer, support, and maintenance. It serves advocates and councils in the United Kingdom and internationally. The company was founded in 1994 and is headquartered in Belfast, the United Kingdom with additional offices in London, the United Kingdom; Chicago, Illinois; and Washington, District of Columbia.

Axis Three is the market leader and pioneer of 3D surgical simulation tools for the cosmetic surgery market. Through its partnership with Siemens and its ground-breaking simulation software based on physics-driven tissue typing, Axis Three promises to create the new standard for 3D predictive surgical simulation.

Avalon is a developer, manufacturer and seller of scientific analytical instrumentation based on Raman spectroscopy techniques.

Kainos Software Limited is a privately held software company headquartered in Belfast, Northern Ireland that develops information technology solutions for businesses and organisations particularly in the public, healthcare and financial services sectors. The company also provides consulting and support services. Kainos has offices in the UK, Ireland, Poland and the U.S., and provides services to its customers across Europe, the Middle East, Africa and North America. Kainos is one of Workday’s main implementation partners for the Workday SaaS product, and have developed Kainos Smart, an automated testing tool for Workday implementations. In the UK, Kainos provide an electronic medical record product for the digitisation of patient notes in the NHS called Evolve. The company also has a long-standing partnership with Autonomy delivering projects to organisations in Europe and Africa. Kainos has been a Microsoft Gold Certified Partner for more than 10 years, and was one of Microsoft's first Gold partners. Today, Kainos is one of Northern Ireland's largest high-tech companies, and one of the top companies in the UK and Ireland.